AWS and the NHL Unveil New Face-off Probability Stat to Bring Hockey Fans Closer to the Action on the Ice
New machine learning stat predicts which player is more likely to win a face-off before…
New machine learning stat predicts which player is more likely to win a face-off before…
MetTel to offer customers a managed SASE service powered by VMware SASE NEW YORK &…
LIMERICK, Ireland–(BUSINESS WIRE)–#AMCSNews–AMCS, the world’s leading technology provider for the waste, recycling and resource management…
Unifies STACK Brand to Provide Global Hyperscale, Cloud and Enterprise Customers with Fully Integrated Offering…
Saint Herblain (France), March 1, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
Marks the first commercial implementation of Verizon Business’ On Site 5G private network solution in…
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cyble, an AI-powered, Y Combinator-backed, cyber threat intelligence company that empowers organizations with…
New WNC Single-box Dual-band mmWave Smart Repeaters Powered by Movandi Shipping and Available Today Enables…
WARREN, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — In a release issued under…
IRVINE, Calif.–(BUSINESS WIRE)–Allen Matkins, a California-based, full-service real estate and business law firm, announced today…
Deal deepens iCapital’s relationship with one of the fastest growing Asian private banks and accelerates…
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (Nasdaq: COSM), an…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
OTO-313 Phase 2 trial in tinnitus fully enrolled ahead of schedule with top-line results expected…
Cash and cash equivalents totaled €258.8 million as of December 31, 2021, which includes the…
— First Participants Dosed in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of…
RAS(ON) Inhibitor Pipeline Continues to Advance and Expand, Now Addressing Majority of RAS-Addicted Cancers; Two…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and…